It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...
An automated production cell is a connected manufacturing system in which machines, robots, controls, sensors, and material-handling equipment work together with limited manual intervention. What ...
The need for cell therapy production improvements is acute, which in turn lends support to approaches like Cellares’ and Ori’s, Tracxn said in its report ...
When most people think of cancer care, they rarely associate it with what goes on behind the scenes to create life-saving treatments. For starters, developing cell and gene therapies is pricey, and ...
As CGT programs scale, sponsors are looking beyond manufacturing capabilities to evaluate supply chain continuity, ...
To qualify for advanced manufacturing technology designation from the FDA, a company must present a manufacturing approach that incorporates a new technology or uses an established technology in a ...
Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...
Ottawa, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The global cell and gene therapy manufacturing market size was calculated at USD 21.15 billion in 2025 and is expected to reach around USD 215.18 billion by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results